ABSTRACT Heterotrimeric G protein Gα 13 is known to transmit G protein-coupled receptor (GPCR) signals leading to activation of RhoA and plays a role in cell migration. The mechanism underlying the role of Gα 13 in cell migration, however, remains unclear. Recently we found that Gα 13 interacts with the cytoplasmic domain of integrin β 3 subunits in platelets via a conserved ExE motif. Here we show that a similar direct interaction between Gα 13 and the cytoplasmic domain of the integrin β 1 subunit plays a critical role in β 1 -dependent cell migration. Point mutation of either glutamic acid in the Gα 13 -binding 767 EKE motif in β 1 or treatment with a peptide derived from the Gα 13 -binding sequence of β 1 abolished Gα 13 -β 1 interaction and inhibited β 1 integrin-dependent cell spreading and migration. We further show that the Gα 13 -β 1 interaction mediates β 1 integrin-dependent Src activation and transient RhoA inhibition during initial cell adhesion, which is in contrast to the role of Gα 13 in mediating GPCR-dependent RhoA activation. These data indicate that Gα 13 plays dynamic roles in both stimulating RhoA via a GPCR pathway and inhibiting RhoA via an integrin signaling pathway. This dynamic regulation of RhoA activity is critical for cell migration on β 1 integrin ligands.
INTRODUCTION
G protein-coupled receptors (GPCRs) transmit signals via the heterotrimeric G proteins and are important, working in concert with β 1 integrins, for directed cell migration (Sakai et al., 1998a (Sakai et al., ,b, 1999 . Gα 13 is among the G proteins important in the directed cell migration and chemotaxis in various cell types (Goulimari et al., 2005; Bian et al., 2006; Rieken et al., 2006) . It has been believed that this role of Gα 13 is mediated via the Gα 13 -dependent activation of RhoGEFs, including p115RhoGEF (ARHGEF1), which subsequently activates the small GTPase RhoA (Kozasa et al., 1998; Suzuki et al., 2003; Radhika et al., 2004; Goulimari et al., 2005; Kreutz et al., 2007) . RhoA activates actomyosin-mediated contraction through inhibition of myosin light chain phosphatases (Kimura et al., 1996) and increases actin polymerization through activation of formin (mDia1), events that are important for cell migration (Goulimari et al., 2005) .
The integrin family of adhesion receptors mediates cell adhesion and migration on extracellular matrices and is important in many physiological and pathological processes, such as development, wound healing, immunity, thrombosis, and cancer metastasis (Hynes, 2002; Ley et al., 2007; Li et al., 2010; Margadant and Sonnenberg, 2010; Huttenlocher and Horwitz, 2011; Seguin et al., 2015) . In particular, the widely expressed β 1 integrins are critical for regulating anchorage-dependent cell survival, proliferation, and migration on extracellular matrices. Integrins transmit signals bidirectionally: high-affinity ligand binding to integrins can be activated by "inside-out" signaling (Ginsberg et al., 2005) , whereas ligand binding induces "outside-in" signaling (Shattil, 2005) . Outside-in signaling elicits a cascade of intracellular signaling events, resulting in two essential cellular responses to the extracellular matrix proteins: cell spreading (formation of protrusions, filopodia and lamellipodia) and cell retraction, both of which are important in driving cell migration , and Xiaoping Du amplification of thrombus formation (Gong et al., 2010; Shen et al., 2013) . Of interest, Gα 13 binding to the integrin β 3 subunit requires an ExE motif that is highly conserved among most integrin β subunits, including β 1 (Shen et al., 2013) . Thus we hypothesized that Gα 13 might also be important in mediating signaling of β 1 integrins. In this study, we demonstrate that the interaction of Gα 13 with integrin β 1 plays a critical role not only in β 1 integrin-mediated cell spreading, but also in β 1 -dependent cell migration on the on extracellular matrices (Huttenlocher and Horwitz, 2011; Shen et al., 2012) . It is unclear how integrins signal to coordinate cell spreading and retraction and mediate cell migration. It is also unclear whether there is a connection between the roles of Gα 13 and integrins in cell migration.
Recently we found that the platelet integrin β 3 subunit binds directly to Gα 13 , and the Gα 13 -β 3 binding plays a critical role in integrin α IIb β 3 -mediated outside-in signaling, cell spreading, and defective wound healing in Gα 13 -knockdown cells was not due to inhibited cell growth but instead to suppressed cell migration.
The interaction of Gα 13 with β 1 integrins via the ExE motif
We previously showed that Gα 13 directly interacts with integrin β subunits via a conserved ExE motif (Shen et al., 2013) . To determine whether Gα 13 interacts with β 1 via the 767 EKE sequence, we incubated purified Gα 13 with Sepharose beads conjugated with purified glutathione bead-bound glutathione S-transferase-Wt β 1 integrin cytoplasmic domain fusion protein (GST-β 1 CD) or with GST-β 1 CD carrying mutations that change the 767 EKE sequence to AKA or AAA. Gα 13 binds directly to the GST-β 1 CD Sepharose beads, whereas Gα 13 failed to bind to the AKA or AAA mutants ( Figure 3A) . Thus the ExE motif is crucial in the direct binding of Gα 13 to integrin β 1 CD. To study whether the interaction between intact β 1 subunit and Gα 13 occurs in cells, we also introduced a set of mutations in the 767 EKE sequences changing EKE to AKE, EKA, AKA, or AAA and expressed these mutants in GD25 cells at similar levels ( Figure 2A) . We then performed coimmunoprecipitation experiments using these cells. There was little integrin β 1 associated with Gα 13 in suspended cells ( Figure 3B ). However, after cell adhesion on fibronectin for 1 h, the interaction becomes prominent ( Figure 3B ). This suggests that integrin ligation is required for the binding of Gα 13 to β 1 in these cells. Furthermore, AKE or EKA mutants showed significantly reduced Gα 13 -β 1 association, and mutation of the glutamic residues (AKA or AAA) almost totally abolished the interaction ( Figure 3B ). Thus the β 1 integrin ExE motif is critical for Gα 13 -β 1 interaction in cells. Consistent with previous results in β 3 integrins (Shen et al., 2013) , AAA mutation in β 1 did not inhibit talin association with β 1 integrin, which was in fact slightly increased ( Figure 3C ), suggesting that AAA mutation selectively abolished Gα 13 -β 1 interaction without inhibiting talin binding.
The interaction between Gα 13 and β 1 integrins mediates β 1 -dependent cell migration
To determine the importance of Gα 13 -β 1 interaction in β 1 -dependent cell migration, we used the scratched wound-healing assay to examine the migration of GD25 cells expressing Wt β 1 or various β 1 ExE motif mutants. The β 1 /Gα 13 -dependent cell migration was partially abolished in cells with AKE mutation in integrin β 1 and was totally abolished in cells expressing AKA, AAA, or EKA mutant (Figure 4, A and B) . Mutations in the β 1 ExE motif did not affect proliferation of these β 1 -expressing cells ( Figure 4C) . Thus it appears that Gα 13 -integrin interaction is responsible for the role of Gα 13 in cell migration, and Gα 13 -β 1 interaction is critically important for β 1 -dependent cell migration.
To determine the role of Gα 13 -integrin interaction in cell migration under different conditions, we also used a transwell migration assay. The integrin β 1 ligand fibronectin was coated on the bottom side of a transwell insert with 8-μm pores, which allow cells on the top side to migrate through the pores to the bottom side of the insert. As shown in Figure 5 , transwell migration of GD25 cells requires β 1 integrin expression. Gα 13 knockdown abolished transwell extracellular matrix. Furthermore, we show that, in contrast to the previously reported role of Gα 13 in the activation of RhoGEF/RhoA pathway (Kozasa et al., 1998; Suzuki et al., 2003) , the Gα 13 -β 1 interaction mediates transient inhibition of RhoA signaling pathway through activation of Src (Arthur et al., 2000) . Thus our studies suggest a new mechanism in which the dynamic regulation of the RhoA signaling pathway by Gα 13 occurs through its binding to RhoGEF GTPases and β 1 integrins. This novel mechanism is critical for β 1 integrin-dependent cell migration.
RESULTS

The importance of Gα 13 in cell migration
To assess the role of Gα 13 in cell migration, we developed two Gα 13 -specific short hairpin RNAs (shRNAs) and their corresponding nonspecific scrambled control shRNA using a lentiviral vector. Transfection of the Gα 13 -specific shRNA, but not the scrambled control, resulted in ∼90% knockdown of Gα 13 in CHO cells ( Figure 1A) , which express endogenous β 1 and β 5 integrins but not β 3 integrins (Ylanne et al., 1993) . We used a scratched wound-healing assay to assess the role of Gα 13 in cell migration. As shown in Figure 1B , 20 h after the scratch, CHO cells and CHO cells transfected with control shRNA had migrated to almost seal the gap. In contrast, Gα 13 -knockdown cells were defective in migration ( Figure 1 , B and C).
The process of scratched wound healing consists of both cell proliferation and cell migration. To exclude the possibility that the phenotypes we observed were attributed to suppression of cell proliferation, we demonstrated that CHO cells with Gα 13 knockdown were not defective in cell proliferation, but instead cell proliferation was slightly increased compared with control ( Figure 1D ). Thus these data indicate that Gα 13 plays an important role in migration of CHO cells.
The role of Gα 13 in β 1 integrin-dependent cell migration
To determine specifically the role of Gα 13 in β 1 integrin-dependent cell migration, we analyzed cell migration in GD25 cells, an embryonic stem cell-derived fibroblast-like cell line originated from β 1 integrin-knockout mice (Wennerberg et al., 1996) , and GD25 cells transfected with wild-type (Wt) or mutant integrin β 1 subunits ( Figure 2A ).
The β 1 −/− GD25 cells displayed severely impaired migration in a scratched wound-healing assay after 20 h ( Figure 2B ). In contrast, Expression of β 1 integrin in GD25 cells corrected the defective migration ( Figure 2B ). These data are consistent with a previous study showing that β 1 expression in β 1 -knockout cell lines enhanced cell migration (Sakai et al., 1998a (Sakai et al., ,b, 1999 Gimond et al., 1999) , indicating that GD25 cell migration in the scratched wound-healing analysis is dependent upon integrin β 1 . Moreover, knockdown of Gα 13 in the β 1 -expressing GD25 cells using either of the two Gα 13 shRNAs caused significant defects in cell migration (Figure 2 , B-D), indicating that Gα 13 plays a critical role in β 1 -integrin-mediated cell migration. Similar to the aforementioned experiments using CHO cells, Gα 13 knockdown did not inhibit, but instead mildly increased cell proliferation compared with control ( Figure 2E ), indicating that the were achieved by cell sorting with FITC-conjugated anti-β 1 antibody K20. β 1 −/− GD25 cells were used as negative control, and the quantification of the relative fold changes of K20 staining is shown (n = 3). (B) Phase contrast images of β 1 (Wt)GD25 cells, with or without Gα 13 -specific or scrambled control shRNA lentiviral transfection, before and after 20 h migration following wound scratches. (C) Western blot comparison of Gα 13 expression levels in β 1 (Wt)GD25 cells and β 1 (Wt)GD25 cells transfected with Gα 13 -specific or scrambled control shRNA. α-Tubulin was used as loading control. Quantitative data are shown in the bar graph (mean ± SD, n = 3). (D) Quantification of data as shown in B (mean ± SD, n = 6). (E) Total cell count at 24-h time point (five experiments). Cell count at 0 h is 0.5 × 10 3 .
Gα 13 -mediated β 1 integrin outside-in signaling and the consequent cell membrane movement (spreading and retraction) are responsible for their functions during cell migration. Thus we investigated how Gα 13 knockdown affects integrin-dependent cell spreading. CHO cells with Gα 13 knockdown were defective in spreading on immobilized integrin ligand fibronectin ( Figure 6 , A and B), suggesting the importance of Gα 13 in integrin-dependent cell spreading. Previous studies showed that early-phase cell spreading on fibronectin was defective in β 1 −/− GD25 cells (Wennerberg et al., 1996; Pankov et al., 2003; Green et al., 2009) . Our data also show that early-phase cell spreading of GD25 cells on fibronectin is dependent on β 1 integrins. GD25 cells expressing the β 1 ExE motif mutants exhibited diminished early-phase cell spreading to a similar level as observed in β 1 -deficient GD25 cells ( Figure 6C ), suggesting that the Gα 13 -integrin interaction is important in β 1 -mediated outside-in signaling leading to β 1 -dependent cell spreading.
Gα 13 -β 1 binding mediates outside-in signaling through activation of c-Src and transient inhibition of RhoA
To determine whether and how Gα 13 binding to β 1 mediates integrin outside-in signaling, we seeded Wt and mutant β 1 -expressing GD25 cells onto immobilized fibronectin and measured Src activation (indicated by phosphorylation at Y416) and RhoA activity (indicated by RhoA pull down with GST rhotekin Rho binding domain protein [RBD] (Ren et al., 1999) , which specifically binds to active RhoA) at different time points after adhesion. Adhesion of the β 1 (Wt)GD25 cells on fibronectin resulted in robust but transient RhoA inactivation (Figure 7, A and B) . In contrast, this transient RhoA inactivation was not observed in β 1 (AAA)GD25 cells, which showed constant activation of RhoA ( Figure 7, A and B) . Furthermore, Src was activated in Wt β 1 -expressing GD25 cells after adhesion to fibronectin, and Src activation was inhibited in the AAA mutant β 1 -expressing GD25 cells (Figure 7, C and D) . Because it is known that transient RhoA inhibition after β 1 outside-in signaling is Src dependent (Arthur et al., 2000) , our data indicate that Gα 13 binding to the ExE motif of β 1 integrins mediates Src activation and Src-mediated inhibition of RhoA signaling. To explore further the role of the Gα 13 -binding β 1
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ExE motif in regulating RhoA activity after cell adhesion, GD25 cells adherent to immobilized fibronectin were stained with the GST-rhotekin RBD (Ren et al., 1999; Figure 8) . Indeed, Wt but not AAA mutant β 1 -expressing cells showed a transient reduction in GST-RBD staining ( Figure 8A ). The staining of the GST-RDB was specific, as it was abolished by Rho inhibitor C3-transferase, and GST protein alone failed to stain the cells ( Figure 8A ). Thus these data indicate that transient RhoA inhibition soon after cell adhesion (30 min) depended on Gα 13 -β 1 interaction ( Figure 8B ).
The effect of an inhibitor peptide based on the Gα 13 -binding sequence in β 1
The foregoing results indicate that integrin β 1 -Gα 13 binding plays an important role in β 1 integrin-mediated activation of Src and transient inhibition of RhoA and in β 1 -dependent cell migration. Thus we hypothesize that an inhibitor of β 1 -Gα 13 interaction should inhibit β 1 -dependent integrin outside-in signaling and cell migration. To test this hypothesis, we synthesized a myristoylated, cell-permeable peptide containing the Gα 13 -binding ExE motif, mβ 1 P 6 (Myr-FEKEKM). Preincubation of this peptide with β 1 (Wt)GD25 cells abolished the interaction of Gα 13 to integrin β 1 in the coimmunoprecipitation assay ( Figure 9A ). In contrast, the scrambled control peptide mβ 1 P 6 Scr (Myr-EKMFEK) had no effect. These data indicate that mβ 1 P 6 is effective in inhibiting Gα 13 -β 1 interaction ( Figure 9A ). migration almost completely. Similar to the scratched wound-healing assay, the AKE mutant of β 1 only partially supported transwell migration, and the EKA, AKA, and AAA mutants had very little activity ( Figure 5, A and B) . Furthermore, AAA mutation or Gα 13 knockdown significantly inhibited transwell migration when fibronectin coating was replaced with collagen coating ( Figure 5C ). On the basis of these results, we conclude that Gα 13 -β 1 interaction is required for the β 1 -dependent cell migration.
The role of Gα 13 -β 1 interaction in mediating β 1 integrin outside-in signaling leading to cell spreading Next we wanted to determine the mechanism responsible for the importance of Gα 13 -integrin interaction in β 1 -dependent cell migration. We previously showed that Gα 13 binding to the integrin β 3 is important in α IIb β 3 outside-in signaling and consequent cell spreading (Shen et al., 2013 ). Hence we hypothesize that FIGURE 3: The critical role of the β 1 ExE motif in the Gα 13 -β 1 interaction. (A) Binding of purified recombinant Gα 13 to glutathione bead-bound glutathione S-transferase (GST), GST-Wt β 1 cytoplasmic domain fusion protein (GST-β 1 Wt), GST-(AKA)β 1 , and GST-(AAA)β 1 mutants. (B) β 1 GD25 cells expressing similar levels of wild-type (Wt) β 1 and various ExE β 1 mutants (AKE, EKA, AKA, or AAA) were allowed to adhere to fibronectin for 1 h. After 1 h, cells were lysed, and cell lysates were immunoprecipitated with anti-Gα 13 antibody or an equal amount of control rabbit IgG. Immunoprecipitates were immunoblotted with anti-Gα 13 and anti-β 1 antibodies. (C) β 1 GD25 cells expressing similar levels of Wt and AAA mutant β 1 were allowed to adhere to fibronectin. After 1 h, cells were lysed, and cell lysates were immunoprecipitated with integrin β 1 antibody or IgG. Immunoprecipitates were immunoblotted with anti-talin and anti-β 1 antibodies.
binding to RhoGEFs (Goulimari et al., 2005; Chen et al., 2012) . Thus our data suggest that Gα 13 -mediated dynamic regulation of RhoA activity is a novel mechanism responsible for the role Gα 13 during β 1 integrin-dependent cell migration.
The importance of integrin β 1 in cell migration has been reported in various cell types (White et al., 2004; Liu et al., 2010) . In addition, evidence has also been given for a role for Gα 13 in directed cell migration (Radhika et al., 2004; Shan et al., 2006; Tan et al., 2006) . However, it was not previously appreciated why and how β 1 integrins and Gα 13 play important roles in mediating cell migration and whether there is a connection. Here we show that integrin β 1 -dependent cell migration requires direct binding of Gα 13 to the cytoplasmic domain of β 1 , establishing a direct connection between these two important molecules in cell migration. Recently we showed that Gα 13 interacts with the platelet Preincubation of mβ 1 P 6 but not the scrambled peptide also significantly inhibited transwell migration in β 1 (Wt)GD25 cells ( Figure 9 , B and C). Furthermore, c-Src activity and transient RhoA inactivation were both inhibited by this inhibitor (Figure 9 , D-G), mirroring the results of ExE mutation (Figure 7 ). Thus this inhibitory peptide of β 1 -Gα 13 interaction was an effective blocker of integrin β 1 -mediated outside-in signaling and cell migration.
DISCUSSION
In this study, we demonstrated that Gα 13 directly binds to the ExE motif of integrin β 1 cytoplasmic domain, and this binding is required for β 1 outside-in signaling and cell migration on the β 1 integrin ligand fibronectin. Of importance, we showed that Gα 13 -integrin interaction mediates transient RhoA inhibition, which is in contrast to the well-known role of Gα 13 in mediating RhoA activation by integrin α IIb β 3 and plays an important role in α IIb β 3 outside-in signaling (Shen et al., 2013) . Migration is not ordinarily considered or studied as an activity of platelets, and it is unclear whether Gα 13 -β 3 interaction is a common mechanism of integrin signaling that is shared with β 1 integrin signaling and important in cell migration. Furthermore, there are major differences in outside-in signaling mechanisms between platelet β 3 integrins and β 1 integrins in nucleated cells. In particular, β 3 outside-in signaling requires Src binding to the C-terminal site of β 3 , which can be cleaved by calpain (Arias-Salgado et al., 2003; Flevaris et al., 2007) . Calpain cleavage of β 3 cytoplasmic domain abolishes c-Src binding and switches β 3 integrin signaling from mediating cell spreading to retraction (Flevaris et al., 2007) . However, Src does not appear to bind to β 1 C-terminus (Arias-Salgado et al., 2003) , and thus its interaction with β 1 is likely to be regulated in a different way. Furthermore, β 1 signaling was reported to involve complex formation of focal adhesion kinase (FAK) with Src and integrin and FAK-dependent Src activation (Xing et al., 1994; Thomas et al., 1998) , which has not been shown in platelet α IIb β 3 . We recently showed that platelet α IIb β 3 -dependent activation of Src requires Gα 13 binding to β 3 (Gong et al., 2010; Shen et al., 2013) . Here we further show that Gα 13 directly binds to the ExE motif in β 1 . Disruption of Gα 13 -β 1 binding through mutations in the ExE motif or use of an ExE motif peptide abolished β 1 -dependent Src activation and inhibited β 1 -dependent outside-in signaling and cell spreading. These data indicate that, despite the difference between β 1 and β 3 signaling, the ExE motif-containing integrins β 1 and β 3 share similar Gα 13 -dependent mechanisms of Src activation and outside-in signaling in platelets and migrating nucleated cells. Of importance, our data for the first time indicate that the interaction between Gα 13 and β 1 ExE motif plays a critical role in integrin-dependent cell migration.
Our data not only indicate the important role for the Gα 13 -β 1 interaction in cell migration, but they also suggest a novel mechanism of Gα 13 -dependent dual regulation of RhoA activity in migrating cells (Figure 10 ). Cell migration on β 1 integrin ligands involves coordinated integrin-dependent cell spreading and retraction. The alternate protrusion and retraction occur during cell spreading at the leading edge (Machacek et al., 2009; Tkachenko et al., 2011) . Retraction in the rear of a cell pulls the cell forward (Lauffenburger and Horwitz, 1996; Ridley et al., 2003) . The Rhofamily GTPase RhoA is a major regulator of cell retraction. RhoA activates Rho kinase. Rho kinase inhibits myosin light chain (MLC) phosphatase and increases MLC phosphorylation, resulting in actomyosin-mediated cell retraction (Kimura et al., 1996) , which drives inward movement of cell membranes. Thus RhoA activity inhibits cell spreading and stimulates cell retraction (Vega et al., 2011) . Consequently, RhoA-dependent retractile signaling needs to be dynamically activated and inhibited in order for cells to migrate. On activation by GPCRs, Gα 13 directly stimulates RhoGEFs and activation of RhoA (Kozasa et al., 1998) , which is believed to be the reason that Gα 13 is important in cell migration (Bian et al., 2006; Patel et al., 2014) . Here we for the first time demonstrate the other aspect of this dynamic regulation. We show that Gα 13 binding to β 1 ExE motif mediates β 1 integrindependent activation of Src and transient inhibition of RhoA in migrating cells. This finding is not only consistent with previous data suggesting that integrin β 1 outside-in signaling transiently inhibits RhoA activity via Src during cell spreading (Arthur and Burridge, 2001 ), but it also provides a plausible mechanism for FIGURE 5: The interaction between Gα 13 and β 1 integrins mediates β 1 -dependent transwell migration. (A) GD25 cells without or with expression of similar levels of wild-type (Wt) β 1 and various ExE β 1 mutants (AKE, EKA, AKA, or AAA) or β 1 (Wt)GD25 cells transfected with scrambled or Gα 13 -specific shRNA were compared in a transwell migration assay with fibronectin coated on the bottom side of the insert well. Cells were fixed and stained with crystal violet after 6 h of migration. (B) Quantification of migrated cells in A (mean ± SD, four experiments). (C) Wild-type or AAA mutant β 1 GD25 cells or Wt β 1 GD25 cells transfected with scrambled or Gα 13 -specific shRNA were compared in the transwell migration assay as described in A, with the exception of collagen coating on the bottom side. Cells were fixed and stained with crystal violet after 6 h of migration. Numbers of migrated cells were compared (mean ± SD, three experiments).
(sc18), anti-integrin β 1 K20 (sc18887), and anti-integrin β 1 JB1B (sc59829) antibodies were from Santa Cruz Biotechnology (Dallas, TX); anti-Gα 13 (26004) was from NewEast Biosciences (King of Prussia, PA); anti-phospho-Src Y 416 antibody was from Cell Signaling Technology (Danvers, MA); anti-GST tag antibody and Alexa Fluor 555 conjugate were from EMD Millipore (Billerica, MA); Lipofectamine 2000, ViraPower Lentiviral Expression System, and Alexa Fluor 546-conjugated phalloidin were from Invitrogen (Carlsbad, CA); fibronectin was from BD Biosciences (Franklin Lakes, NJ); the Active Rho Pull-Down and Detection Kit was from Pierce, Thermo Scientific (Waltham, MA).
Cell culture
CHO (Gu et al., 1999; Xi et al., 2003) , 293FT, and GD25 cells were cultured in DMEM complete (Cellgro) supplemented with 10% fetal bovine serum (FBS; Corning), 2 mM l-glutamine (Corning), 100 U/ml penicillin plus 100 μg/ml streptomycin (Corning), 1 mM sodium pyruvate (Gibco), 0.1 mM nonessential amino acids (Gibco), and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer (Gibco). Cells were serum starved in DMEM containing each of the foregoing components except the FBS for at least 4 h before experiments.
initiating Src-dependent transient RhoA inhibition. Thus our data, together with the previously reported role of Gα 13 in activating RhoA, suggest a novel mechanism by which dynamic regulation of RhoA activation by Gα 13 is achieved: Gα 13 binding to ligandbound integrins induces Src-dependent transient inhibition of RhoA, which is required for cell spreading. On the other hand, Gα 13 binding to RhoGEFs stimulates RhoA and thus drives cell retraction together with RhoA activation induced by late-phase integrin signaling (Dubash et al., 2007) . Dynamic regulation of RhoA activation by Gα 13 thus provides a novel mechanism explaining the importance of Gα 13 in driving coordinated cell spreading and retraction, leading to cell migration.
MATERIALS AND METHODS Reagents
Human integrin β 1 cDNA was cloned into plenti6/V5-DEST vector after digestion with EcoRI and XhoI. Integrin E-to-A mutants were generated using PCR and cloned into plenti6/V5-DEST vector by EcoRI and XhoI. GST-β 1 CD and recombinant Gα 13 purification was described previously (Shen et al., 2013) . Anti-RhoA antibody was from Cytoskeleton (Denver, CO); anti-Gα 13 (sc410), anti-c-Src washes with the NP40 buffer, bound Gα 13 was analyzed by SDS-PAGE and Western blots with antibodies against Gα 13 .
Cell-spreading assay
Cultured cells were detached with 0.053 mM EDTA and resuspended in serum-free DMEM (Flevaris et al., 2007) . Cells were allowed to spread on 10 μg/ml fibronectin-coated coverslips for different time points, fixed, permeabilized, stained with Alexa Fluor 546-conjugated phalloidin, and viewed with a Leica RMI RB microscope as previously described (O'Brien et al., 2012; Shen et al., 2013) . Quantification of the surface area of spreading cells was performed using ImageJ (National Institutes of Health, Bethesda, MD).
Wound-healing assay
Similar to what was previously described (Liang et al., 2007) , cells were cultured until subconfluent and serum starved in serum-free DMEM for at least 6 h before the experiment. After starvation, scratches were made using p200 pipet tips, and DMEM complete was supplied to the cells. Cell migration and wound healing were monitored by taking pictures at selected time points using bright-field microscopy.
Lentiviral infection and integrin β 1 reconstitution
Gα 13 shRNA lentivirus was prepared as described previously (Gong et al., 2010) . Briefly, pLL3.7-scrambled shRNA or pLL3.7-Gα 13 shRNA (#1 and #2) were cotransfected into subconfluent 293FT cells with pLP1, pLP2, and pLP/VSVG plasmids (Invitrogen) using Lipofectamine 2000. After 48 h, cell culture supernatant was collected, filtered, and used to infect CHO or GD25 cells. Similarly, expression of integrin β 1 in GD25 cells was achieved by infecting GD25 cells with 293FT supernatant after plenti6-V5-DEST-β 1 transfection using the ViraPower Lentiviral Expression System. Expression of Wt or mutant β 1 integrin on the GD25 cell surface was assayed by flow cytometry using fluorescein isothiocyanate (FITC)-conjugated anti-integrin β 1 antibody K20.
Purified Gα 13 binding to integrin β 1 cytoplasmic domains GST-tagged integrin β 1 cytoplasmic domain proteins were incubated with purified recombinant Gα 13 at 4°C overnight in NP40 buffer (50 mM Tris, pH 7.4, 10 mM MgCl 2 , 150 mM NaCl, 1% NP-40, 1 mM sodium orthovanadate, 1 mM NaF) with complete protease inhibitor cocktail tablets (1 tablet/5 ml buffer; Roche). After three 
Transwell migration assay
Fibronectin or collagen (30 μg/ml) was coated on the outer surface of 6.5-mm transwell inserts with 8-μm pore size (Corning) overnight at room temperature. The insert was washed with phosphate-buffered saline (PBS) and blocked with 2% bovine serum albumin in PBS for 30 min at 37°C. Serumstarved cells in DMEM with 0.5% FBS were seeded on the upper chamber of the insert and allowed to migrate for 6 h in a 37°C incubator. After that, cells on the outer surface were fixed with 3.7% paraformaldehyde, stained with crystal violet, and visualized with bright-field microscopy (Huttenlocher et al., 1996) .
Coimmunoprecipitation
As previously described (Shen et al., 2013) , cells expressing Wt or mutant human integrin β 1 were solubilized in NP40 lysis buffer with complete protease inhibitor cocktail tablets (1 tablet/5 ml buffer; Roche). Lysis debris was cleared after centrifugation at 14,000 × g for 10 min. Lysates were then immunoprecipitated with rabbit anti-Gα 13 immunoglobulin G (IgG) or an equal amount of control rabbit IgG for at least 6 h before protein A/G Sepharose beads were added. After incubation of protein A/G Sepharose beads for 45 min at 4°C, beads were centrifuged down and washed six times with NP40 lysis buffer. Immunoprecipitates were analyzed by immunoblotting using anti-β 1 antibody JB1B or anti-Gα 13 antibody (26004).
In situ RhoA immunofluorescence assay GD25 cells were allowed to spread on immobilized fibronectin (10 μg/ml), fixed with 3.7% paraformaldehyde, permeabilized, and incubated with purified GST-RBD proteins as previously described (Flevaris et al., 2007) . Then cells were stained with anti-integrin β 1 antibody conjugated with Alexa Fluor 488 and anti-GST tag antibody conjugated with Alexa Fluor 555 and viewed with a Zeiss LSM510 META confocal microscope.
FIGURE 8:
In situ RhoA activation analysis of the role Gα 13 binding to β 1 . (A) GD25 cells were allowed to adhere to immobilized fibronectin, fixed, and stained with anti-β 1 antibody (green) and GST-RBD proteins (red). β 1 (Wt)GD25 cells were also preincubated with 20 μg/ml C3-transferase and stained with anti-β 1 (green) and GST-RBD (red). Cells stained with anti-β 1 antibody (green) and GST proteins (red) served as additional negative controls. (B) Quantification of the active RhoA in A (mean ± SD, n = 3).
Thermo Scientific), washed, and then immunoblotted with an antiRhoA monoclonal antibody (Ren et al., 1999) .
Peptide inhibitors
Myristoylated peptides mβ 1 P 6 (Myr-FEKEKM) and mβ 1 P 6 Scr (Myr-EKMFEK) were synthesized and purified at the Research Resource Center at the University of Illinois at Chicago. The peptides were prepared in dimethyl sulfoxide for use in biochemistry experiments, dissolved in DMEM complete, and filtered for transwell migration experiments.
Images were analyzed using ImageJ, and the quantification of the total fluorescence per cell, which is associated with RhoA activity, was performed using the corrected total cell fluorescence.
Src phosphorylation and RhoA activity assay
Cells in modified Tyrode's buffer or adherent on immobilized fibronectin were solubilized in cold NP40 lysis buffer at 4°C, and debriscleared lysates were immunoblotted for phospho-Src Y418, total cSrc, or total RhoA. To measure the RhoA activity, debris-cleared lysates were incubated for 1 h with purified GST-RBD beads (Pierce, FIGURE 9: The inhibitory effects of a myristoylated peptide mβ 1 P 6 on Gα 13 -β 1 interaction, cell migration, c-Src activation, and transient RhoA inactivation. (A) β 1 (Wt)GD25 cells treated with 100 μM β 1 mP 6 or scrambled control peptide β 1 mP 6 Src were allowed to adhere to fibronectin for 1 h. Cells were lysed, and cell lysates were immunoprecipitated with anti-Gα 13 antibody or an equal amount of control rabbit IgG. Immunoprecipitates were immunoblotted with anti-Gα 13 and anti-β 1 antibodies. (B) Transwell migrated β 1 (Wt)GD25 cells with coated fibronectin 6 h after migration. Cells were treated with 100 μM β 1 mP 6 or scrambled control peptide β 1 mP 6 Src before migration and stained with crystal violet after fixation. Number of migrated cells was compared (mean ± SD, n = 3). (C) Quantification of migrated cells using coated collagen (mean ± SD, n = 3). (D-F) β 1 (Wt)GD25 cells treated with 100 μM β 1 mP 6 or scrambled control peptide β 1 mP 6 Src were allowed to adhere to immobilized fibronectin, solubilized at various time points, and analyzed for RhoA activation (D, E) and c-Src Tyr416 phosphorylation (F, G). (D, F) typical gels. (E, G) Quantification of the Western blots (mean ± SD, n = 3).
